Cooper Companies (NASDAQ:COO) Stock Rating Upgraded by Wall Street Zen

Cooper Companies (NASDAQ:COO - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Friday.

Several other research analysts have also recently weighed in on the stock. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Wells Fargo & Company decreased their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research note on Friday. Robert W. Baird lowered their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Thursday, May 22nd. Finally, Citigroup reduced their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $100.38.

Cooper Companies Stock Down 13.8%

Shares of Cooper Companies stock traded down $11.02 on Friday, reaching $68.94. The company's stock had a trading volume of 8,291,770 shares, compared to its average volume of 1,531,454. Cooper Companies has a 52 week low of $65.95 and a 52 week high of $112.38. The firm's fifty day simple moving average is $79.82 and its two-hundred day simple moving average is $88.37. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $13.79 billion, a price-to-earnings ratio of 35.35, a P/E/G ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the company earned $0.85 EPS. Cooper Companies's revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts anticipate that Cooper Companies will post 3.98 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. raised its stake in Cooper Companies by 2.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock worth $705,928,000 after acquiring an additional 155,233 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Cooper Companies by 3.4% in the first quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company's stock worth $436,681,000 after purchasing an additional 172,485 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Cooper Companies by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after purchasing an additional 109,907 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Cooper Companies by 17.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after buying an additional 686,751 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.